Am Pharma

Proscalpin 1mg is a generic medicine prescribed for the treatment of male pattern baldness, also called Androgenic Alopecia. This condition is characterized by the progressive thinning and losing of hair in men. There are a few factors responsible for causing hair fall in men.

Proscalpin is categorized as a type II reductase inhibitor. This means that this drug inhibits the functioning of 5-alpha reductase. This is an enzyme that is necessary to be transformed into the scalp, which is a hormone variation that has been identified as responsible for follicle death and the loss of hair. Through the inhibition of the conversion process, Proscalpin lowers the levels of DHT and slows down the hair loss process.

It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells.

Tamodex 20mg Tablet is an anti-estrogens. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells.

Tamodex 20mg Tablet is also helpful in the treatment of infertility. It can be taken with or without food, but take it at the same time to get the most benefit. It should be taken as your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. This medicine is generally taken for 10 to 15 years. You should take this medicine for as long as it is prescribed for you.

Vintor Solution For Injection is used for the treatment of anaemia that occurs because of cancer chemotherapy, HIV infection treatment with zidovudine, or kidney disease.

Vintor 10000IU Injection is a medicine that helps your bone marrow to produce more red blood cells. It is used to treat a type of anemia caused by kidney disease. It is also used to treat anemia caused by cancer chemotherapy and by taking medicines to treat HIV.

It is used in treating advanced breast cancer in post-menopausal women. Fempro Tablet is additionally indicated to be used in anovulatory infertility for induction of ovulation. This medicine should be taken as instructed by your doctor. The dose and frequency will be decided by your doctor.
Fempro Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.

Erlotinib (brand name Tarceva) is an oral chemotherapy medication that is primarily used to treat specific types of cancer. The 150 mg Erlotinib tablets are typically used for the following conditions:

1. Non-Small Cell Lung Cancer (NSCLC):

   • Erlotinib is commonly used to treat non-small cell lung cancer (NSCLC), particularly in patients whose cancer has specific genetic mutations such as EGFR (epidermal growth factor receptor) mutations. Erlotinib works by inhibiting the EGFR tyrosine kinase, which plays a role in cancer cell growth and spread. It is typically used as a first-line treatment or for patients whose disease has progressed on chemotherapy.

2. Pancreatic Cancer:

   • Erlotinib is used in combination with chemotherapy (usually with gemcitabine) to treat advanced pancreatic cancer. It is given to patients whose pancreatic cancer is inoperable or metastatic, helping to slow down the growth of cancer cells.

3. Other Cancers:

   • Although not as common, erlotinib may be used in clinical trials or in treatment regimens for other cancers, such as head and neck cancers or ovarian cancer, depending on the individual case and patient response to other treatments.

Mechanism of Action: Erlotinib works by inhibiting the activity of the EGFR (epidermal growth factor receptor), a protein found on the surface of certain cancer cells. EGFR activation leads to the growth and spread of these cells, and by blocking this receptor, erlotinib helps prevent cancer cell proliferation.

Dosage: The usual starting dose of erlotinib for NSCLC is 150 mg once daily, but this may vary depending on the specific condition, individual response, and the presence of side effects. It is taken as a tablet by mouth, typically on an empty stomach or at least one hour before or two hours after a meal to ensure optimal absorption.

Common Side Effects include:

• Diarrhea
• Rash (especially acne-like rashes on the face, chest, and back)
• Fatigue
• Loss of appetite
• Nausea

Serious side effects can include:

• Lung problems (e.g., shortness of breath, cough)
• Liver problems
• Gastrointestinal perforations
• Eye irritation or dryness

Tamoxifen Citrate (brand names include Nolvadex, Tamofen, and others) is a medication that is primarily used for the treatment and prevention of breast cancer. It is a selective estrogen receptor modulator (SERM) that works by interfering with the effects of estrogen, a hormone that can promote the growth of certain types of breast cancer. The 10 mg Tamoxifen Citrate tablet is typically used for the following conditions:

1. Treatment of Breast Cancer:

• Tamoxifen is commonly used in the treatment of hormone receptor-positive breast cancer (estrogen receptor-positive or ER+ breast cancer), which is the most common type of breast cancer. It can be used in both early-stage and advanced-stage breast cancer.
• For early-stage breast cancer, tamoxifen is typically given after surgery (and sometimes radiation therapy) to reduce the risk of recurrence.
• For advanced-stage (metastatic) breast cancer, tamoxifen can be used to slow the progression of the disease.

2. Breast Cancer Prevention:

• Tamoxifen is also used for the prevention of breast cancer in women who are at high risk of developing the disease due to family history, genetic factors, or other risk factors.
• It is prescribed to women with a history of ductal carcinoma in situ (DCIS) or other non-invasive forms of breast cancer to help prevent the development of invasive breast cancer.

3. Adjuvant Therapy (Post-surgery):

• Tamoxifen is often used as adjuvant therapy following surgery for breast cancer. It helps reduce the chance of cancer recurrence by blocking the estrogen receptor, preventing estrogen from stimulating cancer cell growth.
• It is typically taken for 5-10 years after surgery, depending on the patient’s individual risk factors.

4. Treatment for Male Breast Cancer:

• While less common, tamoxifen is also used in male breast cancer, especially for hormone receptor-positive cases. It works similarly to its use in women by blocking the estrogen receptor and reducing the growth of cancer cells.

Chlorambucil is a chemotherapy medication used primarily to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma. The 2 mg Chlorambucil tablet is typically prescribed for:

1. Chronic Lymphocytic Leukemia (CLL): It helps reduce the number of cancerous white blood cells in the body.
2. Hodgkin's Lymphoma: Chlorambucil can be part of combination chemotherapy treatments for this type of cancer.
3. Non-Hodgkin's Lymphoma: It may be used in certain cases of non-Hodgkin's lymphoma.
4. Autoimmune Diseases: In some cases, chlorambucil may be prescribed for autoimmune conditions, such as lupus, to suppress immune system activity.

It works by interfering with the DNA inside the cancerous cells, preventing them from multiplying.

Important: Chlorambucil should only be used under the supervision of a healthcare provider due to its potential side effects and toxicity.

Cytotam 10 Tablet 10's contains Tamoxifen, which is an anti-oestrogen drug. It treats breast cancer that has spread to other parts of the body in men and women. Cytotam 10 Tablet 10's is also used to treat breast cancer in women who are earlier treated with surgery, radiation, and chemotherapy.

Abiraterone acetate (500 mg tablets) is a medication primarily used in the treatment of prostate cancer. It is an oral drug that works by inhibiting the production of androgens (male hormones like testosterone), which can stimulate the growth of prostate cancer cells. The main uses of Abiraterone acetate include:

1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Abiraterone acetate is primarily used for metastatic castration-resistant prostate cancer (mCRPC). This type of prostate cancer continues to progress even when testosterone levels are reduced to very low levels through treatments such as surgery (orchiectomy) or medications (androgen deprivation therapy).
• By inhibiting CYP17A1, an enzyme involved in androgen production, Abiraterone reduces the production of testosterone and other androgens, slowing the growth of prostate cancer cells.

2. High-Risk Castration-Sensitive Prostate Cancer (CSPC)

• Abiraterone acetate is also used in high-risk castration-sensitive prostate cancer (CSPC), often in combination with other treatments like prednisone and androgen deprivation therapy. This form of prostate cancer is responsive to hormone therapy, but may still require additional treatment to reduce the risk of progression.

How It Works:

Abiraterone acetate blocks the enzyme CYP17A1, which is involved in producing testosterone and other androgens in the adrenal glands, testes, and prostate cancer cells. By reducing androgen levels, it helps slow the growth of prostate cancer that relies on these hormones for growth and survival.

Administration:

• Abiraterone acetate is typically taken once daily, along with prednisone (a steroid) to manage potential side effects related to the drug's action on cortisol levels.
• The tablets are generally taken on an empty stomach (at least 1 hour before or 2 hours after a meal) to maximize absorption.

Important Considerations:

• Side Effects: Common side effects of Abiraterone acetate include high blood pressure, fluid retention, liver enzyme changes, fatigue, and joint pain. Long-term use can also affect adrenal function.
• Adrenal Insufficiency: Since Abiraterone affects adrenal gland function, patients may experience symptoms of adrenal insufficiency, such as weakness, nausea, or low blood pressure. This is why prednisone is used alongside it to help manage these risks.
• Monitoring: Regular blood tests are required to monitor liver function, blood pressure, and potassium levels during treatment.

Abiraterone acetate should be prescribed and monitored by a healthcare provider, particularly an oncologist, to ensure proper dosing and management of side effects.

200 mg Nilotinib Capsule is a medication primarily used to treat Chronic Myelogenous Leukemia (CML), a type of cancer that affects the blood and bone marrow. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and is marketed under various brand names, including Tasigna.

Main Uses of 200 mg Nilotinib Capsule:

1. Chronic Myelogenous Leukemia (CML):

   • Nilotinib is used in the treatment of CML, particularly in patients with Philadelphia chromosome-positive (Ph+) CML, which means the leukemia cells have a specific genetic abnormality.
   • It is especially used in patients who are resistant or intolerant to other tyrosine kinase inhibitors like imatinib. Nilotinib works by inhibiting the activity of the BCR-ABL fusion protein, a mutant protein that drives the growth of leukemia cells.

2. Accelerated Phase and Blast Crisis of CML:

   • Nilotinib is also indicated for the treatment of patients with accelerated phase or blast crisis of CML, which are advanced stages of the disease where the leukemia is more aggressive.

3. Adjuvant to Other Therapies:

   • Nilotinib may be used in combination with other therapies or following chemotherapy or stem cell transplant to help control and manage CML in patients.

How It Works:

• Nilotinib is a second-generation tyrosine kinase inhibitor that works by specifically targeting and inhibiting the activity of the BCR-ABL fusion protein, which is responsible for the uncontrolled growth of CML cells.
• By blocking this enzyme, Nilotinib disrupts the signaling pathways that drive the cancer cell growth, leading to cell death and a reduction in the number of leukemia cells in the blood and bone marrow.

Administration:

• Nilotinib is taken as an oral capsule, typically once or twice daily, depending on the patient’s condition and the treating physician’s recommendation.
• It should be taken on an empty stomach, at least 2 hours before or 1 hour after food, to ensure proper absorption.
• The usual dose for CML in chronic phase is typically 300 mg twice daily or as determined by the healthcare provider. For patients with more advanced stages (accelerated phase or blast crisis), the dose may be higher.

Side Effects:

Common side effects of Nilotinib may include:

• Nausea
• Headache
• Fatigue
• Rash
• Diarrhea
• Muscle cramps or joint pain
• Elevated liver enzymes
• QT prolongation (a potential heart rhythm problem)

Arimidex 1mg Tablet is used alone or with other treatments, such as surgery or radiation, to treat early breast cancer in postmenopausal women. It can also be used as the first line treatment of advanced breast cancer that has spread within the breast or to other areas of the body.

Arimidex 1 mg Tablet is used in the treatment of breast cancer. It is used with other treatments, such as surgery or radiation, to treat breast cancer in women who have attained menopause.

Erlotero 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Erlotero 150mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.  You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Anabrez 1mg Tablet contains Anastrozole which belongs to the group of medicines called Anti-cancer drugs. It is used in the treatment of breast cancer in women who have undergone menopause. Breast cancer refers to the disease in which there is overgrowth of cells in the breast which may go out of control.

Femistra Tablet is used alone or with other treatments, such as surgery or radiation, to treat early breast cancer in postmenopausal women. It can also be used as the first line treatment of advanced breast cancer that has spread within the breast or to other areas of the body.

Femistra Tablet is an aromatase inhibitor. It works by lowering the amount of estrogen (natural female hormone) produced in the body. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.

40mg Enzalutamide capsules are primarily used in the treatment of prostate cancer, specifically for advanced stages or in cases that are resistant to other treatments. Enzalutamide is an androgen receptor inhibitor, which works by blocking the action of male hormones (androgens) like testosterone, which can fuel the growth of prostate cancer cells.

The primary uses of Enzalutamide (40mg) include:

1. Metastatic Castration-Resistant Prostate Cancer (mCRPC): Enzalutamide is commonly used to treat metastatic castration-resistant prostate cancer. This is a stage of prostate cancer where the disease continues to progress even after the levels of testosterone have been reduced to very low levels (via surgical or medical castration).

2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): It is also used for patients with non-metastatic castration-resistant prostate cancer, where the cancer has not yet spread but is growing despite low testosterone levels.

3. Prostate Cancer after Surgery or Radiation Therapy: Enzalutamide may be used to treat prostate cancer in patients who have undergone prostatectomy (surgery to remove the prostate) or radiation therapy and have experienced cancer recurrence or progression.

4. Hormone-Sensitive Prostate Cancer (in combination): In some cases, enzalutamide is used in combination with other treatments like androgen deprivation therapy (ADT) for patients with hormone-sensitive prostate cancer to help prevent the cancer from progressing.

Mechanism of Action: Enzalutamide works by inhibiting the androgen receptor signaling pathway, which is responsible for promoting the growth of prostate cancer cells. By blocking androgens from binding to these receptors, enzalutamide helps slow down or stop the growth of cancer cells in the prostate.

Administration: Enzalutamide is typically taken orally as a capsule once a day, with or without food. The standard dose is 40 mg per day, but this can vary depending on the specific treatment plan and the patient's response to therapy.

Side Effects: Common side effects of enzalutamide include:

• Fatigue
• Hot flashes
• Muscle weakness
• High blood pressure
• Diarrhea
• Seizures (in rare cases)
• Risk of falls and fractures due to its effect on bone health
• Mood changes, including depression

Precautions: Enzalutamide should be used with caution in patients with a history of seizures, liver problems, or other medical conditions. It is important to monitor patients regularly for potential side effects. Enzalutamide can also cause a decrease in sperm count and fertility, so men who are planning to have children should discuss options with their healthcare provider.

Overall, enzalutamide is an effective treatment for advanced prostate cancer, especially in cases where the disease has become resistant to standard hormone therapy. However, it requires close monitoring due to its potential side effects.

Enzalutamide is a medication primarily used in the treatment of prostate cancer. The 80 mg Enzalutamide capsules are typically prescribed for the following uses:

1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Enzalutamide is commonly prescribed for men with metastatic castration-resistant prostate cancer (mCRPC). This is a form of prostate cancer that continues to grow despite treatment to lower testosterone levels (castration). Enzalutamide works by blocking the androgen receptors that allow the cancer cells to grow in response to testosterone.

2. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

• Enzalutamide is also used to treat men with non-metastatic castration-resistant prostate cancer (nmCRPC). These are cases where the cancer has not yet spread, but the disease is progressing despite low testosterone levels.

3. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

• Enzalutamide may be used in combination with other treatments, such as androgen deprivation therapy (ADT), for metastatic hormone-sensitive prostate cancer. This is a stage where prostate cancer responds to hormone therapy (like lowering testosterone).

Mechanism of Action:

Enzalutamide works by inhibiting the androgen receptor signaling, which prevents the prostate cancer cells from using testosterone to grow and divide. This helps slow down the progression of the cancer.

Important Points:

• Enzalutamide is typically prescribed when other treatments, such as surgery or radiation, are no longer effective or the cancer has metastasized.
• It can also help improve overall survival rates in prostate cancer patients with advanced stages.
• Enzalutamide may be used with other medications, including chemotherapy or other prostate cancer treatments, depending on the individual's condition.

Side Effects: Common side effects may include fatigue, hot flashes, dizziness, high blood pressure, and liver enzyme elevations. Patients should be closely monitored by healthcare professionals.

Important: Enzalutamide should only be taken under the supervision of an oncologist due to its potential side effects and interactions with other medications.

Enzandro 160 mg Tablet is a medication primarily used in the management of Benign Prostatic Hyperplasia (BPH), a condition where the prostate gland enlarges, leading to urinary symptoms such as difficulty urinating, frequent urination, or incomplete emptying of the bladder. The main active ingredient in Enzandro is Enzalutamide, which is also used in the treatment of prostate cancer, particularly in cases that have become resistant to other treatments.

Enzalutamide 40 mg is primarily used in the treatment of prostate cancer, particularly in advanced or metastatic stages. It is an androgen receptor inhibitor that works by blocking the effects of male hormones (androgens), such as testosterone, on prostate cancer cells.

It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells.

Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is in a class of medications called kinase inhibitors.

It is used to treat: hormone dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen. hormone dependent advanced breast cancer in postmenopausal women when a different hormonal drug treatment has not worked well enough.

Capecitabine which belongs to the group of medicines called Anti cancer medicines It is used in the treatment of colon rectal gastric and breast cancer CAPEGARD 500MG TABLET is also used to prevent new occurrence of colon cancer after complete removal of the tumor by surgery

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Geftib Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Capecad 500mg Tablet is used  in the treatment of cancer of breast, colon, and rectum. It may be also used to treat other conditions, as determined by the doctor. It is used alone or in combination with some other medicine as a part of chemotherapy.

Nitib 140mg Tablet is used to treat Mantle cell lymphoma, chronic lymphocytic leukaemia, and Waldenstr's macroglobulinaemia. It contains Ibrutinib, which works by blocking Bruton's tyrosine kinase, a protein in the body that helps cancer cells grow and survive. Thereby, it kills and reduces the number of cancer cells.

NITIB 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Imbruvica 140mg Capsule is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Imbruvica 140mg Capsule contains Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of several types of blood cancers. Ibrutinib works by blocking BTK, a protein that helps cancer cells survive and grow. By inhibiting this protein, Imbruvica interferes with the growth and spread of cancer cells, particularly in certain types of leukemia and lymphoma.

Capecitabine Dispersible Tablets is used in the treatment of cancer of breast, colon, and rectum. It may be also used to treat other conditions, as determined by the doctor. It is used alone or in combination with some other medicine as a part of chemotherapy.

Capebel DT 500mg Tablet contains the active ingredient Capecitabine. It belongs to the category of medicines known as antimetabolites. This medication is used in combination with other anticancer drugs for the treatment of Metastatic colorectal cancer and breast cancer.

Vivitra 150mg Injection is used in the�treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein). Vivitra 150mg Injection is given as an injection by a qualified medical professional.

Xtane Tablets contain Exemestane (25 mg), an aromatase inhibitor primarily used for the treatment of hormone-sensitive breast cancer in postmenopausal women. Exemestane works by lowering estrogen levels in the body, which helps slow or stop the growth of certain breast cancer cells that rely on estrogen to grow.

Uses of Xtane (Exemestane) Tablets:

1. Hormone-Receptor Positive Breast Cancer (Adjuvant Treatment):

   • Xtane is used as a part of adjuvant therapy (post-surgery treatment) to reduce the risk of breast cancer recurrence in postmenopausal women with estrogen receptor-positive (ER+) early breast cancer.

2. Advanced or Metastatic Breast Cancer:

   • It is also prescribed to treat advanced or metastatic breast cancer in postmenopausal women whose disease has progressed after treatment with other hormonal therapies like tamoxifen.

3. Switch Therapy:

   • Xtane may be used in a sequential treatment strategy following 2-3 years of tamoxifen therapy, completing a total of 5 years of hormonal therapy.

How Xtane (Exemestane) Works:

• Exemestane belongs to a class of drugs known as aromatase inhibitors.
• It blocks the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogen in postmenopausal women.
• By reducing estrogen levels, it helps prevent the growth and spread of hormone-sensitive breast cancer cells.

Common Side Effects:

• Hot flashes
• Joint and muscle pain
• Fatigue
• Nausea
• Headache
• Increased sweating
• Osteoporosis (bone thinning)

Serious Side Effects:

• Bone fractures due to decreased bone mineral density
• Liver dysfunction (elevated liver enzymes)
• Cardiovascular issues (rare)

Precautions:

1. Bone Health:
   • Since Exemestane can lead to bone loss, monitoring bone density is recommended. Calcium and vitamin D supplements may be prescribed.
2. Liver and Kidney Function:
   • Liver and kidney function should be monitored, especially in patients with pre-existing conditions.
3. Pregnancy and Breastfeeding:
   • Xtane should not be used in pregnant or breastfeeding women as it can harm the fetus or infant.
4. Drug Interactions:
   • Avoid using estrogen-containing medications (like hormone replacement therapy) while on Xtane, as they can reduce its effectiveness.

Geftib 250 mg (active ingredient: Gefitinib) is primarily used in the treatment of certain types of cancer. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and specifically targets cancer cells with certain mutations.

Lenvatinib 10 mg Capsule Uses:

Lenvatinib is a tyrosine kinase inhibitor (TKI) that blocks several signaling pathways involved in tumor growth and angiogenesis (formation of new blood vessels). It is used to treat various types of cancers.

Uses of Lenvatinib 10 mg Capsule:

1. Thyroid Cancer:

   • Lenvatinib is used to treat radioiodine-refractory differentiated thyroid cancer (DTC), meaning the cancer does not respond to radioactive iodine therapy.

2. Hepatocellular Carcinoma (HCC):

   • It is used as a first-line treatment for unresectable liver cancer (hepatocellular carcinoma) in patients who cannot undergo surgery.

3. Renal Cell Carcinoma (RCC):

   • Lenvatinib is used in combination with pembrolizumab or everolimus to treat advanced kidney cancer (renal cell carcinoma) after other treatments have failed.

4. Endometrial Cancer:

   • In combination with pembrolizumab, lenvatinib is used to treat advanced endometrial carcinoma in patients who cannot undergo surgery or radiation, particularly if the disease is microsatellite stable or mismatch repair-proficient.

How Lenvatinib Works:

• Lenvatinib inhibits multiple receptor tyrosine kinases (RTKs), including those involved in vascular endothelial growth factor (VEGF) signaling pathways.
• By blocking these pathways, it slows tumor growth, reduces blood supply to the tumor, and limits the spread of cancer

It is an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer. The most common side effects of this medicine include tiredness, joint pain, muscle pain, nausea, and vomiting.

Arsenox 10mg Injection is used in the treatment of blood cancer (Acute lymphocytic leukemia).
Arsenox 10mg Injection is given as an infusion into veins under the management of a specialist, with normal observing of pulse. Your PCP will conclude what portion is vital and how frequently you really want to take it. This will rely upon what you are being treated for and may change now and again. You ought to take it precisely as your primary care physician has prompted. Misinterpreting it in or taking a lot of can cause intense secondary effects. It might require a little while or months for you to see or feel the advantages yet don't quit taking it except if your primary care physician tells you to.
The most widely recognized results of this medication incorporate queasiness, regurgitating, expanded pulse, rash, and weariness. It could cause expanded blood glucose level, illuminate your primary care physician assuming that you experience outrageous thirst, hunger or regular pee and obscured vision. Normal blood tests are expected to screen your blood calcium, potassium, and creatinine, previously and during treatment with this medication. You will likewise be checked for ECG previously and during the treatment.

Pazopanib Hydrochloride 400 mg Tablets are used primarily in the treatment of certain types of cancer. Pazopanib is an oral tyrosine kinase inhibitor that targets various enzymes involved in cancer cell growth and the formation of blood vessels (angiogenesis) that support tumor growth.

Primary Uses of Pazopanib Hydrochloride 400 mg Tablets:

1. Renal Cell Carcinoma (RCC)

   • Pazopanib is commonly used to treat advanced or metastatic renal cell carcinoma (RCC), which is a type of kidney cancer. Pazopanib works by inhibiting the activity of vascular endothelial growth factor (VEGF) receptors, platelet-derived growth factor (PDGF) receptors, and c-kit, all of which are involved in tumor growth and blood vessel formation. By blocking these pathways, it helps to slow or stop the growth of the cancer.

2. Soft Tissue Sarcoma (STS)

   • Pazopanib is also approved for the treatment of soft tissue sarcoma (STS) in patients who have received prior chemotherapy. Soft tissue sarcoma is a rare cancer that arises in the connective tissues, muscles, fat, or other soft tissues in the body. Pazopanib inhibits the growth of cancer cells by blocking the signals required for their growth and survival.

How Pazopanib Works:

Pazopanib is a multi-targeted tyrosine kinase inhibitor. It blocks the action of several enzymes (receptors), including VEGF receptors and PDGF receptors, which play critical roles in the development of new blood vessels that tumors need to grow (angiogenesis). By inhibiting these pathways, pazopanib can reduce tumor size and the spread of cancer cells.

Common Side Effects:

• Fatigue
• Diarrhea
• Nausea and vomiting
• Hypertension (high blood pressure)
• Loss of appetite
• Hair color change
• Skin rash
• Hand-foot syndrome (redness, swelling, pain in hands and feet)
• Liver enzyme abnormalities
• Weight loss

Serious Side Effects (Less Common):

• Liver damage (hepatotoxicity)
• Cardiovascular issues, such as heart failure or QT interval prolongation
• Severe bleeding or blood clotting disorders
• Gastrointestinal perforation (a hole in the digestive tract)
• Severe infections due to immune suppression

Precautions:

• Liver Function: Pazopanib can cause liver toxicity, so liver function tests should be conducted regularly during treatment.
• Blood Pressure Monitoring: It can cause hypertension, so blood pressure should be monitored regularly.
• Heart Health: Pazopanib may affect heart function, so heart health should be monitored, especially in patients with pre-existing cardiovascular conditions.
• Pregnancy Category D: Pazopanib should not be used during pregnancy due to the risk of harm to the fetus. Effective contraception is advised for women of childbearing age.
• Drug Interactions: Pazopanib can interact with other medications, particularly those affecting liver enzymes (CYP450). It’s important to inform healthcare providers of all medications, including over-the-counter drugs and supplements.

Lapatinib Ditosylate 250 mg Tablets is an oral medication primarily used for the treatment of certain types of breast cancer. It is a tyrosine kinase inhibitor that works by blocking the signals that promote cancer cell growth. 

Tykerb 250mg Tablet is used in the treatment of breast cancer It shows its working by stopping or slowing down the growth of cancer cells It is either used alone or in combination with some other medicine to cure advanced stage of breast cancer

This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It works by slowing or stopping the growth of cancer cells.

Imatib 400 Tablet is used to treat several types of cancers. It is most commonly prescribed to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. It works by targeting specific proteins that contribute to the growth and spread of cancer cells.

Imatib 400 Tablet is also used for treatment of a skin tumor called dermatofibrosarcoma protuberans and a type of bone marrow condition called aggressive systemic mastocytosis. The medicine should be taken with food. Take it at the same time each day to get the most benefit. Continue taking it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Veenat 400 Tablet 10's belongs to a class of drugs known as 'anti-cancer medication' containing Imatinib, primarily used to treat various cancer types. It is used to treat cancer of the blood (chronic myeloid leukaemia and acute lymphocytic leukaemia) and gastrointestinal stromal tumour.

Veenat 400 Tablet 10 s belongs to a class of drugs known as anti cancer medication containing Imatinib primarily used to treat various cancer types It is used to treat cancer of the blood chronic myeloid leukaemia and acute lymphocytic leukaemia and gastrointestinal stromal tumour

Ramiven 150mg Tablet is an anticancer medication containing the active ingredient Abemaciclib. It is used to treat certain types of breast cancer (hormone receptor-positive, HER2 negative breast cancer) that are advanced or metastatic (breast cancer that has spread to other parts of the body).

This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It works by slowing or stopping the growth of cancer cells.

We sell best quality 
Imatinib mesylate (Generic Glivec) Tablets for the treatment of Blood cancer (Chronic myeloid leukaemia) and Gastrointestinal stromal tumour

Mitant 12.5mg Capsule is a medicine used in the treatment of kidney cancer and gastrointestinal stromal tumor. It works by blocking specific enzymes that promote the growth of cancer cells. This way it shrinks the tumor and slows down its progression.Mitant 12.5mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Cantret Capsule is used to treat cancer of the ovaries. It may also be used to treat other types of cancer as determined by your doctor. It can be given alone or in combination with certain other medicines as part of combination chemotherapy.